Duodenal Neuroendocrine Tumour Resection With a New Duodenal Full Thickness Resection Device

Pinto, João Cortez; Ferro, Susana Mão de; Castela, Joana; Claro, Inês; Chaves, Paula; Pereira, António Dias

doi:10.1055/s-0039-1681947

Search citation statements

Order By: Relevance

Paper Sections

Select...

Ampullary D-nets1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Non-Ampullary d-NETs Small (≤1 cm) G1/G2 d-NETs without local or distant metastases are eligible for ER. Several ER methods have been proposed, including ESD, EMR, EMR with ligation devices, hybrid-EMR, underwater submucosal resection, endoscopic full-thickness resection (EFTR), and recently endoscopic banding without resection [33][34][35][36][37][38][39][40].…”

Section: Ampullary D-netsmentioning

confidence: 99%

Neuroendocrine Tumors of the Gastrointestinal Tract: A Focused Review and Practical Approach for Gastroenterologists

Carvão

Dinis-Ribeiro

Pimentel‐Nunes

et al. 2021

GE Port J Gastroenterol

View full text Add to dashboard Cite

Neuroendocrine tumors (NETs) are rare tumors derived from the neuroendocrine cell system, and more commonly found in the gastrointestinal (GI) tract. Over the last decades, the incidence of GI-NETs has been steadily increasing, partly due to the expanding indications for endoscopy. Most patients with NETs are asymptomatic, and their NETs are noticed during screening examinations; thus, endoscopists are on the frontline of the diagnosis of GI-NETs. Since GI-NETs are less frequent than other malignancies, the natural history, diagnosis, and management of these tumors may not be fully understood. In this review, we aim to update the endoscopist on key clinical features and management of patients with gastric, duodenal, and rectal NETs.

show abstract